Literature DB >> 21189160

Beta-carboline alkaloids harmaline and harmalol induce melanogenesis through p38 mitogen-activated protein kinase in B16F10 mouse melanoma cells.

Sun Young Park1, Young Hun Kim, Young Hee Kim, Geuntae Park, Sang-Joon Lee.   

Abstract

Melanin synthesis is regulated by melanocyte specific enzymes and related transcription factors. β-carboline alkaloids including harmaline and harmalol are widely distributed in the environment including several plant families and alcoholic beverages. Presently, melanin content and tyrosinase activity were increased in melanoma cells by harmaline and harmalol in concentration- and time-dependent manners. Increased protein levels of tyrosinase, tyrosinase-related protein-1 (TRP-1), and TRP-2 were also evident. In addition, immunofluorescence and Western blot analyses revealed harmaline and harmalol increased cAMP response element binding protein phosphorylation and microphthalmia-associated transcription factor expression. In addition to studying the signaling that leads to melanogenesis, roles of the p38 MAPK pathways by the harmaline and harmalol were investigated. Harmaline and harmalol induced time-dependent phosphorylation of p38 MAPK. Harmaline and harmalol stimulated melanin synthesis and tyrosinase activity, as well as expression of tyrosinase and TRP-1 and TRP-2 indicating that these harmaline and harmalol induce melanogenesis through p38 MAPK signaling.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21189160     DOI: 10.5483/BMBRep.2010.43.12.824

Source DB:  PubMed          Journal:  BMB Rep        ISSN: 1976-6696            Impact factor:   4.778


  8 in total

1.  Endocannabinoids stimulate human melanogenesis via type-1 cannabinoid receptor.

Authors:  Mariangela Pucci; Nicoletta Pasquariello; Natalia Battista; Monia Di Tommaso; Cinzia Rapino; Filomena Fezza; Michela Zuccolo; Roland Jourdain; Alessandro Finazzi Agrò; Lionel Breton; Mauro Maccarrone
Journal:  J Biol Chem       Date:  2012-03-19       Impact factor: 5.157

2.  Harmaline and harmalol inhibit the carcinogen-activating enzyme CYP1A1 via transcriptional and posttranslational mechanisms.

Authors:  Mohamed A M El Gendy; Anatoly A Soshilov; Michael S Denison; Ayman O S El-Kadi
Journal:  Food Chem Toxicol       Date:  2011-10-21       Impact factor: 6.023

3.  Peganum harmala Alkaloids Self-Assembled Supramolecular Nanocapsules with Enhanced Antioxidant and Cytotoxic Activities.

Authors:  Sherif Ashraf Fahmy; Marwa Y Issa; Basma M Saleh; Meselhy Ragab Meselhy; Hassan Mohamed El-Said Azzazy
Journal:  ACS Omega       Date:  2021-04-27

4.  Inhibitory Effect of Dried Pomegranate Concentration Powder on Melanogenesis in B16F10 Melanoma Cells; Involvement of p38 and PKA Signaling Pathways.

Authors:  Su Jin Kang; Beom Rak Choi; Eun Kyoung Lee; Seung Hee Kim; Hae Yeon Yi; Hye Rim Park; Chang Hyun Song; Young Joon Lee; Sae Kwang Ku
Journal:  Int J Mol Sci       Date:  2015-10-13       Impact factor: 5.923

5.  Peganum harmala L.'s anti-growth effect on a breast cancer cell line.

Authors:  Somayeh Hashemi Sheikh Shabani; Sahar Seyed Hasan Tehrani; Zohreh Rabiei; Sattar Tahmasebi Enferadi; Gian Paolo Vannozzi
Journal:  Biotechnol Rep (Amst)       Date:  2015-10-27

6.  Melanogenic effect of purified mushroom tyrosinase on B16F10 Melanocytes: A Phase Contrast and Immunofluorescence Microscopic Study.

Authors:  Kamal U Zaidi; Sharique A Ali; Ayesha S Ali
Journal:  J Microsc Ultrastruct       Date:  2016-07-30

7.  The effects of Caffeoylserotonin on inhibition of melanogenesis through the downregulation of MITF via the reduction of intracellular cAMP and acceleration of ERK activation in B16 murine melanoma cells.

Authors:  Hye-Eun Kim; Atsushi Ishihara; Seong-Gene Lee
Journal:  BMB Rep       Date:  2012-12       Impact factor: 4.778

8.  Rice Bran Ash Mineral Extract Increases Pigmentation through the p-ERK Pathway in Zebrafish (Danio rerio).

Authors:  Yu-Mi Kim; Eun-Cheol Lee; Han-Moi Lim; Young-Kwon Seo
Journal:  Int J Mol Sci       Date:  2019-05-02       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.